Navigation Links
PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
Date:6/10/2009

PRINCETON, N.J., June 10 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced its participation at several international professional meetings during the month of June.

    June 23   45th Drug Information Association (DIA) Annual Meeting
              San Diego, California, Booth 321
              Betty Kuhnert, PhD, MBA, Executive Director, Training Services,
              will chair a session entitled Critical Success Strategies for
              Professional Development and will present "So You Have a New
              Job, Now What? Tactics for Surviving a Job Transition."

    June 24   Phacilitate's Active Immunotherapeutics Forum
              Barcelona, Spain
              Joyce Frey-Vasconcells, PhD, Executive Director, PharmaNet
              Consulting, will make a presentation on "Delivering Strategic
              Solutions to Manufacturing and Product Characterization
              Challenges with Allogeneic Therapies."

              AAPS National Biotechnology Conference
              Seattle, Washington, Booth 305
              Taylor Technology's Robert Dodge, PhD, Laboratory Director,
              Immunochemistry and Cell Biology, Jason Morse, Director,
              Information Technology and Lisa Werdal, Database Systems
              Manager, will be presenting their poster: "Development and
              Implementation of an Information Management System for Tiered
              Immunogenicity Sample Testing and Reporting."

              Robert Dodge, PhD, Marisa Castellana, Research Scientist and
              Dania Yaskanin, Associate Director, Immunochemistry, will also
              present their poster entitled "Optimization of Commercial ELISA
              Kits for the Quantitation of Human Luteinizing Hormone and
              Follicle Stimulating Hormone."

    June 30   4th Annual Biopharm Asia Conference
              Singapore
              Duu-Gong Wu, PhD, Executive Director, PharmaNet Consulting, will
              make a presentation entitled "Overview of Follow-on Biologics
              Regulatory and Scientific Issues in US." He will also lead a
              post conference workshop on July 1 on the topic of the FDA's
              approval process for biologics and biological products.

              49th Annual Meeting of the Teratology Society
              Rio Grande, Puerto Rico
              Bengt Danielsson, MD, PhD, Vice President, PharmaNet Consulting,
              will present "Exaggerated Pharmacology Versus True Toxicity."
              Dr. Danielsson's presentation is part of the International Life
              Sciences Institute and the Health and Environmental Sciences
              Institute's (ILSI/HESI) symposium on Maternal Toxicity and its
              Impact on Study Design and Data Interpretation.

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,400 employees and 40 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.

    Contact: Anne-Marie Hess
    Phone: (609) 951-6842
    E-mail: ahess@pharmanet.com


'/>"/>
SOURCE PharmaNet Development Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
2. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
3. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
4. PharmaNet Development Group Agrees to be Acquired by JLL Partners
5. Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
6. Plexus Awarded Development Contract With QIAGEN
7. AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
8. Microbia, Inc. Names Alex Chu as Vice President of Process Development
9. China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug
10. Dr. Chris Huber Joins Asymchem Laboratories Inc. as Director of Chemical Development
11. Cord Blood America to Hold Conference Call on Thursday May 21st at 11 a.m. Eastern Time to Discuss 2009 First Quarter Results and Corporate Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , ... May 02, 2016 , ... ... its clients in mind, the fresh look and added functionality give the agricultural ... years have seen a dynamic shift in agriculture – from precision farming via ...
(Date:4/29/2016)... , ... April 30, 2016 , ... The MIT bioLogic ... design, the bioLogic team explored how bacterial properties can be applied to fabric and ... Natto bacteria, which move in response to humidity change. The team harvested Natto cells ...
(Date:4/29/2016)... , April 29, 2016 ... Transparency Market Research "Separation Systems for Commercial Biotechnology ... Trends, and Forecast 2015 - 2023", the separation ... US$ 10,665.5 Mn in 2014 and is projected ... 2015 to 2023 to reach US$ 19,227.8 Mn ...
(Date:4/29/2016)... ... April 29, 2016 , ... Intelligent Implant Systems announced today that the two-level ... sale in the United States. These components expand the capabilities of the system ... sales beginning in October of 2015, the company has seen significant sales growth in ...
Breaking Biology Technology:
(Date:3/9/2016)... YORK , March 9, 2016 This ... and future states of the RNA Sequencing (RNA Seq) ... segments such as instruments, tools and reagents, data analysis, ... Analyze various segments of the RNA-Sequencing market such as ... services Identify the main factors affecting each segment and ...
(Date:3/8/2016)... , March 8, 2016   Valencell ... technology, today announced it has secured $11M in ... GII Tech, a new venture fund being launched ... additional participation from existing investors TDF Ventures and ... funds to continue its triple-digit growth and accelerate ...
(Date:3/3/2016)... England and DE SOTO, Kansas ... , U.S.-based Stroke Detection Plus® to offer Oncimmune,s ... risk assessment and early detection of lung cancer ... large employers, unions and individuals. --> Early ... unions and individuals. --> Oncimmune, a leader ...
Breaking Biology News(10 mins):